In an in vivo assay, the treatment of PD-L1-expressing colon cancer (MC38)-cell-engrafted C57BL/6 mice model with QL-301 resulted in increased CD8+ T-cell numbers and inhibited tumor growth. Here, CD8A is linked to neoplasm.